Sodium MRI for primary aldosteronism
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study uses a special MRI to measure sodium levels in your body to better understand and treat primary aldosteronism, a condition that can cause hard-to-control high blood pressure. Participating may help doctors learn how to manage your condition more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 70 years old
- You have high blood pressure or your doctor thinks you might have primary aldosteronism
- You can have an MRI (no metal implants, pacemaker, iron tattoos, or severe claustrophobia)
- You do not have serious heart, kidney, liver, or muscle disease, active cancer, or other major health problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.
This study tests two new types of PET/MR scans (68Ga-Pentixafor and 68Ga-FAPI-04) to see if they can better detect the cause of primary aldosteronism — a condition that leads to hard-to-control high blood pressure. The scans may help doctors decide which treatment is best for you.
This Phase 2 study uses a nuclear imaging scan to help doctors sort out which subtype of primary aldosteronism you may have. It may help confirm the right cause and guide more targeted treatment decisions.
This study tests if a 2-day version of the oral salt loading test works as well as the standard 3-day test to diagnose primary aldosteronism (a common cause of high blood pressure). If effective, it could make diagnosis faster and easier for patients.
This trial studies whether a medicine that blocks aldosterone (called an MRA) can improve cardiovascular outcomes in people with high aldosterone levels and high blood pressure. You may be asked to take the study medicine and have blood pressure, heart, and lab tests monitored over time.
This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.